Open AccessIntravitreal bevacizumab as a primary treatment for idiopathic choroidal neovascularization
Author(s) -
RizwanA Cheema,
Javed Mushtaq,
MaheeraA Cheema
Publication year - 2011
Publication title -
middle east african journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.357
H-Index - 25
eISSN - 0975-1599
pISSN - 0974-9233
DOI - 10.4103/0974-9233.84051
Subject(s) - medicine , bevacizumab , ophthalmology , choroidal neovascularization , visual acuity , fluorescein angiography , retinal , prospective cohort study , macular edema , surgery , chemotherapy
To report long-term outcomes of the use of intravitreal bevacizumab in subjects with idiopathic choroidal neovascularization (ICNV).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom